Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124884) titled '5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Federation Francophone de Cancerologie Digestive
Condition:
Colorectal Carcinoma
KRAS G12C Mutation
Unresectable Colorectal Cancer
Intervention:
Drug: Administration of experimental treatment association (sotorasib, panitumumab 5FU)
Recruit...